Adjuvant or Salvage Radiation Therapy for Prostate Cancer after Prostatectomy: Current Status, Controversies and Perspectives

SIMPLE SUMMARY: The management of patients with biochemical recurrence after prostatectomy has undergone significant changes in recent years. Currently, close monitoring of prostate-specific antigen (PSA) with early salvage radiotherapy (RT) in case of recurrence is the standard of care based on sev...

Descripción completa

Detalles Bibliográficos
Autores principales: Terlizzi, Mario, Limkin, Elaine Johanna, Moukasse, Yasmina, Blanchard, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996903/
https://www.ncbi.nlm.nih.gov/pubmed/35406460
http://dx.doi.org/10.3390/cancers14071688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996903/
https://www.ncbi.nlm.nih.gov/pubmed/35406460
http://dx.doi.org/10.3390/cancers14071688

Ejemplares similares